Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» 2seventy bio
2seventy bio
FDA to delay decision on Bristol Myers-2seventy bio cancer therapy
FDA to delay decision on Bristol Myers-2seventy bio cancer therapy
Reuters
Bristol Myers Squibb
2seventy bio
blood cancer
FDA
Abecma
Flag link:
5 FDA decisions to watch in the fourth quarter
5 FDA decisions to watch in the fourth quarter
BioPharma Dive
FDA
Alnylam
Onpattro
ATTR amyloidosis
Vertex Pharmaceuticals
CRISPR Therapeutics
exa-cel
Bluebird Bio
Zynteglo
sickle cell disease
Bristol Myers Squibb
2seventy bio
Abecma
Multiple Myeloma
Amgen
Lumakras
non-small cell lung cancer
Pfizer
estrasimod
ulcerative colitis
Flag link:
2Seventy CEO Leschly to step down as company cuts staff, spending
2Seventy CEO Leschly to step down as company cuts staff, spending
BioPharma Dive
2seventy bio
restructuring
layoffs
Nick Leschly
Flag link:
FDA puts 2seventy CAR-T trial on hold in wake of patient death
FDA puts 2seventy CAR-T trial on hold in wake of patient death
Fierce Biotech
2seventy bio
clinical trials
FDA
patient deaths
AML
CAR-T
Flag link:
Death triggers pause of 2seventy CAR-T cell therapy leukemia trial
Death triggers pause of 2seventy CAR-T cell therapy leukemia trial
Fierce Biotech
2seventy bio
Bluebird Bio
CAR-T
patient death
clinical trials
AML
Flag link:
Bristol Myers claims success in study testing earlier CAR-T use in multiple myeloma
Bristol Myers claims success in study testing earlier CAR-T use in multiple myeloma
BioPharma Dive
Bristol Myers Squibb
2seventy bio
Abecma
CAR-T
Multiple Myeloma
Flag link:
2seventy bio's honeymoon phase is over as job cuts hit 6% of staff
2seventy bio's honeymoon phase is over as job cuts hit 6% of staff
Fierce Biotech
2seventy bio
layoffs
Bluebird Bio
Flag link:
As Abecma sales take off, Bristol Myers and 2seventy scrap a follow-up CAR-T
As Abecma sales take off, Bristol Myers and 2seventy scrap a follow-up CAR-T
Endpoints
Bristol Myers Squibb
2seventy bio
Abecma
bb21217
CAR-T
Flag link:
Bluebird bio completes spinout of oncology business 2seventy bio
Bluebird bio completes spinout of oncology business 2seventy bio
Bizjournals
Bluebird Bio
spinoff
oncology
2seventy bio
Flag link:
bluebird bio provides update on 2seventy bio spin-off
bluebird bio provides update on 2seventy bio spin-off
PM Live
Bluebird Bio
2seventy bio
spinoff
oncology
Flag link:
Bluebird names oncology spinoff, establishes leadership team
Bluebird names oncology spinoff, establishes leadership team
Fierce Biotech
Bluebird Bio
spinoffs
cancer
2seventy bio
Flag link: